Oct 5 (Reuters) – Eli Lilly Co said on Wednesday it
would buy German drugmaker Boehringer Ingelheim’s U.S. pet
vaccines business and a manufacturing plant for $885 million.
The post UPDATE 1-Lilly to buy Boehringer’s U.S. pet vaccines unit appeared first on NASDAQ.